3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids

Schnalzger, Theresa; de Groot, Marnix HP; Zhang, Congcong; Mosa, Mohammed H.; Michels, Birgitta E.; Röder, Jasmin; Darvishi, Tahmineh; Wels, Winfried S.; Farin, Henner F.

3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids

Files

There are no files associated with this item.

Date

2019

Authors

Schnalzger, Theresa

de Groot, Marnix HP

Zhang, Congcong

Mosa, Mohammed H.

Michels, Birgitta E.

Röder, Jasmin

Darvishi, Tahmineh

Wels, Winfried S.

Farin, Henner F.

DOI (citable link)

10.15252/embj.2018100928

Collections

Biologie

Publication type

Journal article

Publication status

Published

Published in

The EMBO journal ; 38 (2019), 12. - e100928. - ISSN 0261-4189. - eISSN 1460-2075

Abstract

Immunotherapy using chimeric antigen receptor (CAR)-engineered lymphocytes has shown impressive results in leukemia. However, for solid tumors such as colorectal cancer (CRC), new preclinical models are needed that allow to test CAR-mediated cytotoxicity in a tissue-like environment. Here, we developed a platform to study CAR cell cytotoxicity against 3-dimensional (3D) patient-derived colon organoids. Luciferase-based measurement served as a quantitative read-out for target cell viability. Additionally, we set up a confocal live imaging protocol to monitor effector cell recruitment and cytolytic activity at a single organoid level. As proof of principle, we demonstrated efficient targeting in diverse organoid models using CAR-engineered NK-92 cells directed toward a ubiquitous epithelial antigen (EPCAM). Tumor antigen-specific cytotoxicity was studied with CAR-NK-92 cells targeting organoids expressing EGFRvIII, a neoantigen found in several cancers. Finally, we tested a novel CAR strategy targeting FRIZZLED receptors that show increased expression in a subgroup of CRC tumors. Here, comparative killing assays with normal organoids failed to show tumor-specific activity. Taken together, we report a sensitive in vitro platform to evaluate CAR efficacy and tumor specificity in a personalized manner.

Subject (DDC)

570 Biosciences, Biology

Cite This

ISO 690

SCHNALZGER, Theresa, Marnix HP DE GROOT, Congcong ZHANG, Mohammed H. MOSA, Birgitta E. MICHELS, Jasmin RÖDER, Tahmineh DARVISHI, Winfried S. WELS, Henner F. FARIN, 2019. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids. In: The EMBO journal. 38(12), e100928. ISSN 0261-4189. eISSN 1460-2075. Available under: doi: 10.15252/embj.2018100928

BibTex

@article{Schnalzger2019-06-17model-47046,
  year={2019},
  doi={10.15252/embj.2018100928},
  title={3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids},
  number={12},
  volume={38},
  issn={0261-4189},
  journal={The EMBO journal},
  author={Schnalzger, Theresa and de Groot, Marnix HP and Zhang, Congcong and Mosa, Mohammed H. and Michels, Birgitta E. and Röder, Jasmin and Darvishi, Tahmineh and Wels, Winfried S. and Farin, Henner F.},
  note={Article Number: e100928}
}

RDF

<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/47046">
    <dc:contributor>Farin, Henner F.</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Schnalzger, Theresa</dc:contributor>
    <dc:creator>de Groot, Marnix HP</dc:creator>
    <dc:creator>Zhang, Congcong</dc:creator>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Schnalzger, Theresa</dc:creator>
    <dc:contributor>Mosa, Mohammed H.</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:abstract xml:lang="eng">Immunotherapy using chimeric antigen receptor (CAR)-engineered lymphocytes has shown impressive results in leukemia. However, for solid tumors such as colorectal cancer (CRC), new preclinical models are needed that allow to test CAR-mediated cytotoxicity in a tissue-like environment. Here, we developed a platform to study CAR cell cytotoxicity against 3-dimensional (3D) patient-derived colon organoids. Luciferase-based measurement served as a quantitative read-out for target cell viability. Additionally, we set up a confocal live imaging protocol to monitor effector cell recruitment and cytolytic activity at a single organoid level. As proof of principle, we demonstrated efficient targeting in diverse organoid models using CAR-engineered NK-92 cells directed toward a ubiquitous epithelial antigen (EPCAM). Tumor antigen-specific cytotoxicity was studied with CAR-NK-92 cells targeting organoids expressing EGFRvIII, a neoantigen found in several cancers. Finally, we tested a novel CAR strategy targeting FRIZZLED receptors that show increased expression in a subgroup of CRC tumors. Here, comparative killing assays with normal organoids failed to show tumor-specific activity. Taken together, we report a sensitive in vitro platform to evaluate CAR efficacy and tumor specificity in a personalized manner.</dcterms:abstract>
    <dc:creator>Farin, Henner F.</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-09-26T13:53:51Z</dcterms:available>
    <dc:contributor>de Groot, Marnix HP</dc:contributor>
    <dc:creator>Michels, Birgitta E.</dc:creator>
    <dc:contributor>Michels, Birgitta E.</dc:contributor>
    <dc:contributor>Zhang, Congcong</dc:contributor>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/47046"/>
    <dc:creator>Mosa, Mohammed H.</dc:creator>
    <dc:creator>Wels, Winfried S.</dc:creator>
    <dcterms:title>3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids</dcterms:title>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Darvishi, Tahmineh</dc:contributor>
    <dc:contributor>Wels, Winfried S.</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-09-26T13:53:51Z</dc:date>
    <dc:language>eng</dc:language>
    <dcterms:issued>2019-06-17</dcterms:issued>
    <dc:creator>Röder, Jasmin</dc:creator>
    <dc:contributor>Röder, Jasmin</dc:contributor>
    <dc:creator>Darvishi, Tahmineh</dc:creator>
  </rdf:Description>
</rdf:RDF>

Refereed

Yes